ATE376840T1 - Gentherapeutika - Google Patents
GentherapeutikaInfo
- Publication number
- ATE376840T1 ATE376840T1 AT00908055T AT00908055T ATE376840T1 AT E376840 T1 ATE376840 T1 AT E376840T1 AT 00908055 T AT00908055 T AT 00908055T AT 00908055 T AT00908055 T AT 00908055T AT E376840 T1 ATE376840 T1 AT E376840T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- affinity
- functional substance
- efficacious amount
- gene therapeutics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7859199 | 1999-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE376840T1 true ATE376840T1 (de) | 2007-11-15 |
Family
ID=13666162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00908055T ATE376840T1 (de) | 1999-03-23 | 2000-03-14 | Gentherapeutika |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060166924A1 (de) |
EP (1) | EP1163912B1 (de) |
KR (1) | KR100674140B1 (de) |
CN (1) | CN1225285C (de) |
AT (1) | ATE376840T1 (de) |
AU (1) | AU2944100A (de) |
DE (1) | DE60036929T2 (de) |
TW (1) | TWI272107B (de) |
WO (1) | WO2000056368A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI315740B (de) | 2001-08-15 | 2009-10-11 | Takara Bio Inc | |
DE60335253D1 (de) | 2002-03-25 | 2011-01-20 | Takara Bio Inc | Verfahren zur produktion eines zytotoxischen lymphozyten |
CN1839202B (zh) | 2003-08-22 | 2012-07-18 | 宝生物工程株式会社 | 细胞毒性淋巴细胞的制备方法 |
CN101243187B (zh) | 2005-08-17 | 2012-07-11 | 宝生物工程株式会社 | 淋巴细胞的制备方法 |
JP5156382B2 (ja) * | 2005-09-30 | 2013-03-06 | タカラバイオ株式会社 | T細胞集団の製造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5686278A (en) * | 1994-03-25 | 1997-11-11 | Indiana University Foundation | Methods for enhanced retrovirus-mediated gene transfer |
JPH09509329A (ja) * | 1994-05-13 | 1997-09-22 | チロン ビアジーン,インコーポレイティド | 遺伝子搬送媒体を標的とする組成物及び方法 |
GB9506466D0 (en) * | 1994-08-26 | 1995-05-17 | Prolifix Ltd | Cell cycle regulated repressor and dna element |
FR2726005B1 (fr) * | 1994-10-10 | 1997-01-03 | Adim | Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques |
US6472204B1 (en) * | 1995-11-13 | 2002-10-29 | Kiyozo Asada | Methods for retroviral mediated gene transfer employing molecules, or mixtures thereof, containing retroviral binding domains and target cell binding domains |
WO1997031656A1 (fr) * | 1996-03-01 | 1997-09-04 | Dnavec Research Inc. | Composition pour introduire de maniere stable des genes dans des cellules hepatiques et procede pour introduire des genes a l'aide de cette composition |
AU4393899A (en) * | 1998-07-01 | 2000-01-24 | Takara Shuzo Co., Ltd. | Gene transfer methods |
-
2000
- 2000-03-14 EP EP00908055A patent/EP1163912B1/de not_active Expired - Lifetime
- 2000-03-14 DE DE60036929T patent/DE60036929T2/de not_active Expired - Lifetime
- 2000-03-14 AT AT00908055T patent/ATE376840T1/de not_active IP Right Cessation
- 2000-03-14 WO PCT/JP2000/001533 patent/WO2000056368A1/ja active IP Right Grant
- 2000-03-14 AU AU29441/00A patent/AU2944100A/en not_active Abandoned
- 2000-03-14 CN CNB008054673A patent/CN1225285C/zh not_active Expired - Fee Related
- 2000-03-14 KR KR1020017011459A patent/KR100674140B1/ko not_active IP Right Cessation
- 2000-03-16 TW TW089104822A patent/TWI272107B/zh not_active IP Right Cessation
-
2006
- 2006-03-28 US US11/390,345 patent/US20060166924A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20010102547A (ko) | 2001-11-15 |
EP1163912A1 (de) | 2001-12-19 |
DE60036929D1 (de) | 2007-12-13 |
EP1163912B1 (de) | 2007-10-31 |
KR100674140B1 (ko) | 2007-01-26 |
AU2944100A (en) | 2000-10-09 |
DE60036929T2 (de) | 2008-08-07 |
TWI272107B (en) | 2007-02-01 |
CN1345248A (zh) | 2002-04-17 |
US20060166924A1 (en) | 2006-07-27 |
CN1225285C (zh) | 2005-11-02 |
WO2000056368A1 (fr) | 2000-09-28 |
EP1163912A4 (de) | 2003-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0316234A (pt) | Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos | |
DK0774005T3 (da) | Overfladeudtrykkelse af enzymer i genorienteret prodrug-terapi | |
DE50211045D1 (de) | Medizinische aerosolformulierungen | |
HN1998000143A (es) | Tetrahidronaftalenos substituidos y compuestos analogos. | |
TR199800046A2 (xx) | Aktif maddeler yarat�lmas� i�in n�kleik asit olu�umu. | |
NO20025450D0 (no) | Ny farmasöytisk sammensetning | |
SV2002000245A (es) | Oxazolidinonas substituidas y su uso ref. lea 34122-sv | |
ATE231509T1 (de) | 1,5-dihydro-pyrazolo 3,4-d)-pyrimidinon-derivate | |
PT751939E (pt) | Naftilamidas como agentes para o sistema nervoso central | |
DE60016798D1 (de) | Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind | |
NO20041773L (no) | Farmasoytiske preparater for reduksjon av cellers aktivitet samt deres anvendelse. | |
ATE376840T1 (de) | Gentherapeutika | |
DE60132443D1 (de) | In lebenden zielzellen | |
ATE478688T1 (de) | Verbindungen für den transfer von oligonukleotiden | |
ATE172721T1 (de) | Aminosäurederivate und ihre verwendung als enkephalinase-inhibitoren | |
SE9803272D0 (sv) | A drug for cell regeneration | |
DK52685A (da) | N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat | |
TR200201148T2 (tr) | Haşerat ilacı terkipleri ve metodları. | |
BRPI0409683A (pt) | 5-hidroxiindóis com grupos n-óxido e seu emprego como agentes terapêuticos | |
WO2000063348A3 (fr) | Composition pharmaceutique comprenant des cellules nkt activees par des pim, et son utilisation en therapie | |
ME00088B (me) | Farmaceutski preparat i njegova priprema | |
DK592885D0 (da) | 2-azolylmethyl-3-difluorbenzyloxy-2,3-dihydrofluor-benzo(b)thiophener, fremgangsmaade til deres fremstilling og kompositioner indeholdendeforbindelserne | |
ATE85186T1 (de) | Verschmolzenes biologisches bekaempfungsmittel. | |
FI20030379A0 (fi) | Uusi farmaseuttinen koostumus | |
BR9915897A (pt) | Agentes de transferência de ácidos nucleicos, composição, utilização de um agente de transferência e processos de tratamento de corpo humano ou animal e de transferência de ácidos nucleicos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |